Therapies/Treatments

A study that was presented this month at the Association of Academic Psychiatrists Annual Meeting suggests that patients being treated for pain with chronic opioid therapy are more likely to live in socially disadvantaged areas and self-report feelings of anxiety, depression and pain more…

Results of a NIDA-supported pilot study released on Monday showed that collaboration between physicians and pharmacists could lead to improved medication adherence among patients being treated for opioid use disorder.

Spark Biomedical, a Texas-based medical device company, announced this week that the FDA has granted 510(k) clearance for its Sparrow Therapy System, a wearable neurostimulation device for the treatment of opioid withdrawal. With FDA clearance obtained, the Sparrow system is now available to U.S.…

Patients diagnosed with depression who also have co-occurring substance use disorders are less likely to receive depression care in line with established best practices, according to a study by researchers from the University of Michigan and the VA Ann Arbor Healthcare System. The findings were…

With the lethality, availability and use of stimulants all greatly increasing in the U.S. in recent years and the COVID-19 pandemic complicating the treatment landscape for patients and practitioners alike, it’s critical for providers to weather the storm, Deni Carise, PhD, chief science officer…

Largely fueled by a surge in methamphetamine and cocaine use, as well as fentanyl, overdose deaths in the United States increased 4.6% in the United States in 2019, NIDA director Nora Volkow, MD, told attendees in a Cocaine, Meth & Stimulant Summit keynote address presented Friday.

Florida-based behavioral healthcare provider Futures Recovery Healthcare announced that it has launched a dedicated residential mental health program. Prior to the launch of the new program, Futures treated mental health disorders only in dual-diagnosis patients who were also dealing with…

In a recent study of mice, researchers from the Department of Psychiatry at the University of Texas Southwestern Medical Center in Dallas found that acute sleep deprivation enhanced the rewarding properties of cocaine use and that blocking the orexin system—the neurons that regulate many body…

Recognizing the toll that the COVID-19 pandemic has taken on the mental health of college students, Caron Treatment Centers has launched a program called Semester of Support to treat primary mental health diagnoses as well as substance use disorders.

Behavioral Innovations, a Denver-based operator of applied behavior analysis therapy providers, announced on Wednesday that it has expanded in Colorado with new centers in Arvada and the Highlands Ranch area of East Littleton, bringing the company’s number of programs in the greater Denver area to…